Home › Funds › Corient Private Wealth LP › JNJ

Corient Private Wealth LP position in JNJ

JOHNSON & JOHNSON · Health Care

Corient Private Wealth LP reported holding 2,274,445 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$577.6M, representing 0.80% of its reported portfolio and ranking #18 among its reported holdings. Corient Private Wealth LP has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.27M sh
Reported value held$577.64M
Portfolio Weight0.80%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Corient Private Wealth LP's JNJ position evolved

Corient Private Wealth LP first disclosed a stake in JNJ in Q3 2023 at 15,900 shares (US$1K). The position peaked in Q1 2026 at 2,666,941 shares, worth US$649.6M. Across 12 filings, Corient Private Wealth LP increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,274,445 shares valued at US$577.6M — a reduction of -392,496 shares quarter over quarter.. Notable position changes include a 17658% increase in Q4 2023 (shares rose 1% over the following quarter), a 16051% increase in Q4 2024 (shares rose 12% over the following quarter), a 17597% increase in Q4 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 15.90K $501 New
Q4 2023 2.82M $442.56M Add
Q1 2024 2.81M $444.40M Reduce
Q2 2024 2.68M $392.03M Reduce
Q3 2024 15.20K $2.46M Reduce
Q4 2024 2.45M $353.63M Add
Q1 2025 2.24M $370.95M Reduce
Q2 2025 2.24M $341.80M Hold
Q3 2025 15.30K $2.84M Reduce
Q4 2025 2.71M $560.32M Add
Q1 2026 2.67M $649.59M Reduce
Q2 2026 2.27M $577.64M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Corient Private Wealth LP held JNJ?

Corient Private Wealth LP has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Corient Private Wealth LP's current position in JNJ?

As of Q2 2026, Corient Private Wealth LP holds 2.27M shares of JNJ (JOHNSON & JOHNSON), valued at $577.64M, representing 0.80% of its reported portfolio and ranking #18.

Has Corient Private Wealth LP been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Corient Private Wealth LP reduced its position in JNJ. The position peaked in Q1 2026 at 2.67M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.